ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company that develops, manufactures, and commercializes therapeutics through its Rare Disease, Generics, and Established Brands businesses. It serves markets in ophthalmology, rheumatology, nephrology, neurology, and pulmonology, and markets products such as ILUVIEN and YUTIQ, acquired through the 2024 acquisition of Alimera Sciences.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.